Tianxin Xiang

机构：Nanchang University, China-Japan Friendship Hospital, First Affiliated Hospital of Jiangxi Medical College, Jiangxi Chest Hospital, First Affiliated Hospital of Nanchang University · ORCID：0000-0002-1673-6077

发表论文 80 篇 · 总被引 1008 次 · h-index 18

代表论文

• Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic (2024 · Nature Communications · 被引 56)
• Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trial (2023 · EClinicalMedicine · 被引 48)
• Time trends in the incidence of interstitial lung disease across Brazil, Russia, India, China and South Africa ( BRICS ) from 1990 to 2019: An age‐period‐cohort analysis (2024 · Respirology · 被引 12)
• Virulence plasmid with IroBCDN deletion promoted cross-regional transmission of ST11-KL64 carbapenem-resistant hypervirulent Klebsiella pneumoniae in central China (2024 · BMC Microbiology · 被引 9)
• Spatial and temporal distribution patterns and factors influencing hepatitis B in China: a geo-epidemiological study (2025 · BMC Public Health · 被引 7)
• Real-world effectiveness and safety of simnotrelvir/ritonavir for COVID-19: A nationwide, multicenter, prospective, observational cohort study in China (2024 · Journal of Infection · 被引 6)